Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Numao

Showing results (391-400 of 419) with videos related to

Pageof 42
Sort By:
Japanese Journal of Clinical Oncology|March 16, 2026
Lymph node metastasis as a favorable prognostic factor in metastatic urothelial carcinoma with histological variants treated with pembrolizumab: a retrospective multicentric study (YUSHIMA study-04)Ichiro Yonese, Fumitaka Koga, Masahiro Toide, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 8, 2026
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying EffectsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
International Urology and Nephrology|April 21, 2026
External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinationsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
Journal of Viral Hepatitis|March 7, 2025
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide AnaloguesJun Inoue, Shinichiro Minami, Kazumichi Abe, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 22, 2025
Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study)Takahiko Soma, Hajime Tanaka, Yuki Nakamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 22, 2014
Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter studyHiroshi Fukushima, Kazutaka Saito, Junichiro Ishioka, et al.
European Urology Focus|July 21, 2017
Ureteral Involvement Is Associated with Poor Prognosis in Upper Urinary Tract Urothelial Carcinoma Patients Treated by Nephroureterectomy: A Multicenter Database StudyYuma Waseda, Kazutaka Saito, Junichiro Ishioka, et al.
Internal Medicine (Tokyo, Japan)|October 19, 2018
No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its VicinityTakuya Hirosawa, Naoki Morimoto, Kouichi Miura, et al.
Japanese Journal of Clinical Oncology|January 28, 2026
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysisShugo Yajima, Soichiro Yoshida, Wei Chen, et al.
The Prostate|March 19, 2026
Real-World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Propensity-Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence SynthesisYosuke Yasuda, Soichiro Yoshida, Shugo Yajima, et al.
Pageof 42

Showing results (391-400 of 419) with videos related to

Sort By:
Pageof 42
Japanese Journal of Clinical Oncology|March 16, 2026
Lymph node metastasis as a favorable prognostic factor in metastatic urothelial carcinoma with histological variants treated with pembrolizumab: a retrospective multicentric study (YUSHIMA study-04)Ichiro Yonese, Fumitaka Koga, Masahiro Toide, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 8, 2026
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time-Varying EffectsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
International Urology and Nephrology|April 21, 2026
External validation of the Meet-URO score in Japanese metastatic renal cell carcinoma patients receiving first-line immune-combinationsShugo Yajima, Soichiro Yoshida, Shohei Fukuda, et al.
Journal of Viral Hepatitis|March 7, 2025
Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Treated With Nucleos(t)ide AnaloguesJun Inoue, Shinichiro Minami, Kazumichi Abe, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 22, 2025
Clinical Features and Risk Factors of Enfortumab Vedotin-Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study (YUSHIMA Study)Takahiko Soma, Hajime Tanaka, Yuki Nakamura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 22, 2014
Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter studyHiroshi Fukushima, Kazutaka Saito, Junichiro Ishioka, et al.
European Urology Focus|July 21, 2017
Ureteral Involvement Is Associated with Poor Prognosis in Upper Urinary Tract Urothelial Carcinoma Patients Treated by Nephroureterectomy: A Multicenter Database StudyYuma Waseda, Kazutaka Saito, Junichiro Ishioka, et al.
Internal Medicine (Tokyo, Japan)|October 19, 2018
No Regional Disparities in Sofosbuvir Plus Ribavirin Therapy for HCV Genotype 2 Infection in Tochigi Prefecture and Its VicinityTakuya Hirosawa, Naoki Morimoto, Kouichi Miura, et al.
Japanese Journal of Clinical Oncology|January 28, 2026
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysisShugo Yajima, Soichiro Yoshida, Wei Chen, et al.
The Prostate|March 19, 2026
Real-World Comparison of Triplet Versus Doublet Therapy in Japanese Patients With High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Propensity-Weighted Analysis From the YUSHIMA Registry and Exploratory Bayesian Evidence SynthesisYosuke Yasuda, Soichiro Yoshida, Shugo Yajima, et al.
Pageof 42